A Estrela-Lima
Overview
Explore the profile of A Estrela-Lima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Figueredo S, Neto R, Ferreira E, Cassali G, Estrela-Lima A, Damasceno K
Res Vet Sci
. 2021 Aug;
140:56-63.
PMID: 34399281
The proteoglycan versican (VCAN) plays a complex role in cancer. The expression of this molecule has been related to invasion and progression in malignant mixed tumors, such as carcinoma in...
2.
Damasceno K, Ferreira E, Estrela-Lima A, Bosco Y, Silva L, Barros A, et al.
Histol Histopathol
. 2015 Dec;
31(6):675-88.
PMID: 26666308
Versican is an extracellular matrix proteoglycan that has been identified as a modulator of adhesion loss, cell motility, and tumour progression. This motility results from the interaction between versican and...
3.
Gamba C, Rodrigues M, Gomes D, Estrela-Lima A, Ferreira E, Cassali G
J Comp Pathol
. 2015 Sep;
153(4):256-65.
PMID: 26385325
E-cadherin downregulation is related to metastatic behaviour and a poor prognosis in cancer. It might be induced by transcriptional repression mediated by the transcription factors SNAIL, ZEB1, ZEB2 and TWIST....
4.
Gamba C, Campos L, Negreiros-Lima G, Maciel-Lima K, Sousa L, Estrela-Lima A, et al.
Res Vet Sci
. 2014 Dec;
97(3):554-9.
PMID: 25447746
ZEB1 and ZEB2 have been recently related to cancer prognosis. We investigated their expression and its association with clinicopathological parameters and overall survival in invasive micropapillary carcinoma (IMPC), which is...
5.
Estrela-Lima A, Araujo M, Soares R, Ribeiro L, Damasceno K, Costa A, et al.
Vet Comp Oncol
. 2014 Feb;
14(1):88-100.
PMID: 24571435
The immunological biomarkers profiles were evaluated using Luminex as putative measures to monitor canine mammary carcinomas (MCs). Forty female dogs were categorized into benign mixed tumour (MC-BMT = 28) and...
6.
Campos L, Lavalle G, Estrela-Lima A, Melgaco de Faria J, Guimaraes J, Dutra A, et al.
J Vet Intern Med
. 2012 Nov;
26(6):1383-8.
PMID: 23113715
Background: Presence of tumor markers in serum might be connected to the number of secreting cells and with the stage of the neoplasm. However, there are few studies regarding these...
7.
Gamba C, Dias E, Ribeiro L, Campos L, Estrela-Lima A, Ferreira E, et al.
Vet J
. 2012 Oct;
196(2):241-6.
PMID: 23031308
Invasive micropapillary carcinoma (IMPC) of the mammary gland, despite its rare occurrence in humans and dogs, is an important neoplasm due to its aggressive behaviour. The aim of this study...